The global whole genome and exome sequencing market witnessed eight significant acquisitions during January 2017 to February 2020. All the acquisitions were aimed at the expansion of the product portfolio by acquiring sequencing-based portfolios with promising growth potential. Also, these acquisitions were intended to strengthen the existing product portfolio for improving accuracy and sensitivity of whole genome and exome sequencing methods. For instance, the acquisition of NEO Oncology AG by Siemens Healthineers, Inc. was aimed at expanding the company's portfolio to cater to the NGS-based molecular diagnostic market for cancer diagnosis and analysis. Further, Agilent Technologies, Inc. company acquired Population genetics for the development of IP portfolio which is aimed at improving accuracy and sensitivity of NGS detection.

1. Product Definition 

2. Research Scope 

3. Research Methodology 

4. Industry Insights 

5. Competitive Landscape

6. Market Dynamics

7. Global Whole Genome and Exome Sequencing Market Overview 

8. Global Whole Genome and Exome Sequencing Market (by Product

9. Global Whole Genome and Exome Sequencing Market (by Workflow) 

10. Global Whole Genome and Exome Sequencing Market (by Application) 

11. Global Whole Genome and Exome Sequencing Market (by End User)

12. Global Whole Genome and Exome Sequencing Market (by Region) 

13. Company Profiles 

14. Appendix